{"id":43034,"date":"2024-10-21T15:38:51","date_gmt":"2024-10-21T13:38:51","guid":{"rendered":"https:\/\/www.maiwald.eu\/?post_type=publikationen&#038;p=43034"},"modified":"2024-11-28T08:57:07","modified_gmt":"2024-11-28T07:57:07","slug":"eu-pharmaceutical-reforms-propose-changes-to-regulatory-protection-periods-managing-ip-2024","status":"publish","type":"publikationen","link":"https:\/\/www.maiwald.eu\/en\/publications\/eu-pharmaceutical-reforms-propose-changes-to-regulatory-protection-periods-managing-ip-2024\/","title":{"rendered":"EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024"},"content":{"rendered":"\n<p>Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for medicinal products.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-43034","publikationen","type-publikationen","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/43034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/types\/publikationen"}],"version-history":[{"count":4,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/43034\/revisions"}],"predecessor-version":[{"id":43729,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/43034\/revisions\/43729"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/media?parent=43034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}